Published: 5 December 2023
Author(s): James Quinn
Issue: March 2024
Section: Commentary

SARS-CoV-2 descended on humanity in 2020 as an acute virus causing millions of excess deaths and suffering [1]. Early research into antibody use, antivirals and the development of vaccines lead to fewer deaths, less hospitalization and severe disease [2,3]. Over time the immunity of the population has improved, variants appear to be less virulent with most people getting back to “normal”. While physicians fought the early battle against severe acute infection, a subgroup of people appeared. These were people who recovered from acute coronavirus disease 2019 (COVID-19) infection but then developed a vague but often debilitating constellation of symptoms [4].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.